Royal Victoria Hospital, Montreal
Intralesional injection of Tisseel fibrin glue used for lymphangioma resection
Published in Managed Care Law Weekly, August 28th, 2005
"Surgical removal of orbital lymphangiomas is often difficult because the capsule of these lesions is fragile, and, once violated, it tends to collapse, making identification of residual tumor difficult and dissection often incomplete.
"A surgical technique combining partial controlled decompression of the lesion with intralesional injection of Tisseel fibrin glue is evaluated to determine its effectiveness in resecting the lesion and preventing recurrences. This is a retrospective interventional case series," scientists writing in the journal Ophthalmic Plastic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
More Articles from Managed Care Law Weekly
- Allscripts Healthcare Solutions
Hawaii insurer to offer TouchWorks EHR to over 600 physicians - Centers for Medicare & Medicaid Services
CMS ending contingency for non-HIPAA-compliant Medicare claims - Elemental Security, Inc.
Company delivers security compliance management product to CHS - Healthcare Coverage
Elderplan expands into the Bronx - Quality Care Solutions Inc.
Information technology provider announces Medicare Part D functionality - Renaissance Health Systems of Florida, Inc.
Community health system now operational in Florida - More from this issue of Managed Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
